{"filings":[{"id":96146,"accession_number":"0001213900-26-050958","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Marpai extends CEO-held promissory notes totaling $660k to Sept 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amended two notes issued to CEO Damien Lamendola: $410k (Feb 2026) and $250k (Mar 2026).","Maturity extended from April 11 and May 10, 2026, respectively, to September 1, 2026.","Interest rate remains 12% per annum; all other terms unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109790,"accession_number":"0001213900-26-025966","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2026-03-11T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Marpai issues $250K promissory note to CEO at 12% for working capital","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal $250,000; interest 12% per annum; payable May 10, 2026.","Note issued to CEO Damien Lamendola; prepayable anytime without penalty.","Proceeds used for general working capital purposes.","Interest rate subject to NY usury cap if lower than 12%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109789,"accession_number":"0001213900-26-016406","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Marpai issues $410K promissory note to CEO Lamendola at 12%, due April 11, 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal $410,000; interest 12% per annum; maturity April 11, 2026.","Note may be prepaid at any time without premium or penalty.","Proceeds used for general working capital purposes.","Holder is CEO Damien Lamendola; prepayment allowed at company's option."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109788,"accession_number":"0001213900-26-007191","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["5.02","1.01"],"status":"ready","headline":"Marpai President resigns; CEO Damien Lamendola appointed as President","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dallas Scrip resigned as President of Marpai effective Jan 30, 2026, with no disagreement with the Company.","Damien Lamendola, age 70, current CEO and Board member, appointed as President effective same date.","Lamendola has been CEO since Nov 2023 and founded Continental Benefits in 2013."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126327,"accession_number":"0001213900-25-124729","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai raises ~$350K via private placement of 350K shares and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 350,000 shares of Class A common stock and warrants to purchase up to 700,000 shares at $1.00/unit.","Gross proceeds ~$350,000; net proceeds for working capital and general corporate purposes.","Warrants exercisable at $1.00/share for 3 years, with anti-dilution provisions.","Offering exempt under Rule 506(b); expected close Dec 22, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126326,"accession_number":"0001213900-25-109369","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai Q3 operating expenses down 24% YoY to $3.8M; net loss narrows to $3.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Operating expenses decreased 24% YoY from $5.0M to $3.8M for Q3 2025.","Operating loss improved 9% YoY from $3.1M to $2.8M; net loss improved 2% to $3.5M.","EPS improved by $0.10 vs prior-year quarter; company targets profitability in Q1 2026.","Completed $3.9M gross PIPE transaction with long-term shareholders; cash flow supports turnaround.","New client contracts signed for Jan 1, 2026, with double-digit growth in base business."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":14111000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126325,"accession_number":"0001213900-25-108593","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai raises ~$4M via private placement of common stock and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 3.85M shares at $1.00 per share plus warrants for 7.7M shares at $1.00, exercisable for 3 years.","Investors include COO/President, chairman, and certain directors of the board.","Gross proceeds approximately $4 million; closing expected on November 7, 2025.","Proceeds to be used for working capital and general corporate purposes.","Warrants have anti-dilution provisions; securities exempt from registration under Rule 506(b)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126324,"accession_number":"0001213900-25-100355","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-10-20T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Marpai amends charter to authorize 2M blank-check preferred shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Certificate of Amendment filed Oct 17, 2025 authorizes 2,000,000 shares of blank-check preferred stock.","Terms, voting, preferences, and rights of each series to be set solely by the Board.","Board approved June 24, 2025; stockholders approved at annual meeting on Aug 27, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126323,"accession_number":"0001213900-25-096526","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai issues 147,058 shares at $1.36 to CEO-controlled fund in private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 147,058 Class A common shares at $1.36 each to HillCour Investment Fund, LLC, controlled by CEO Damien Lamendola.","Gross proceeds of approximately $200,000; transaction exempt under Section 4(a)(2) and Rule 506(b) of Securities Act.","Closing occurred on September 30, 2025; shares are restricted and may not be sold without registration or exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143079,"accession_number":"0001213900-25-087900","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai raises ~$1.1M in private placement; CEO's entity buys 86% of shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 1,038,519 shares at $1.0592/share in unregistered private placement to three investors.","HillCour Investment Fund, controlled by CEO Damien Lamendola, purchased 896,903 shares (approx. $950,000).","Proceeds of ~$1.1M exempt from SEC registration under Section 4(a)(2) and Rule 506(b).","Securities are restricted and cannot be resold without registration or exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143078,"accession_number":"0001213900-25-082077","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Marpai President John Powers resigns; COO Dallas Scrip appointed as successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Powers resigned as President effective Aug 29, 2025, due to personal health; will serve as part-time Senior Consultant.","Board appointed Dallas Scrip, 43, as President; Scrip had been COO since June 2, 2025.","Scrip was President/Chief Delivery Officer at Centivo (2023-2025) and President/GM at ValueHealth (2019-2023).","No disagreements led to Powers' departure; no new compensation or related-party transactions for Scrip."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143077,"accession_number":"0001213900-25-081120","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Marpai shareholders elect 6 directors, ratify UHY, approve blank-check preferred amendment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected: Lamendola (10,978,996 for), Eitan (10,979,296), Shiv (10,932,384), DiClaudio (10,562,391), Calabrese (10,982,991), Pons (10,983,116).","Ratification of UHY LLP as auditor for FY2025: 12,370,958 for, 6,457 against, 13,366 abstain.","Amendment to certificate of incorporation to add 2,000,000 shares of blank-check preferred stock approved: 10,853,406 for, 135,408 against.","Broker non-votes: 1,401,237 on director election and preferred stock amendment; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143076,"accession_number":"0001213900-25-075688","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai Q2 2025: net loss cut 66% to $4.4M; op ex down 70%; CEO targets Q1 2026 profitability","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Operating expenses fell 70% ($9.9M savings) to $3.6M; operating loss reduced 71% to $3.6M.","Net loss improved 66% to $4.4M; net loss per share improved $0.95.","Net revenues were $4.7M, down $2.5M YoY due to transitional impacts.","CEO expects to achieve profitability in Q1 2026; strong 2026 pipeline cited."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":10074000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143075,"accession_number":"0001213900-25-071305","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai raises ~$650k in private placement; CEO entity buys 371k shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 603,640 shares of Class A common stock at $1.0768/share for aggregate proceeds of ~$650,000.","HillCour Investment Fund, controlled by CEO Damien Lamendola, purchased 371,470 shares (61.5% of offering).","Offering exempt from registration under Section 4(a)(2) and Rule 506(b) of Regulation D.","Three investors participated; funds used for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143074,"accession_number":"0001213900-25-066092","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-07-21T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai raises ~$150K in private placement; CEO-affiliated entity buys 86,805 shares at $1.152","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 130,208 shares of Class A common stock at $1.152 per share, raising aggregate proceeds of approximately $150,000.","HillCour Investment Fund (entity controlled by CEO Damien Lamendola) purchased 86,805 shares; other investor bought remaining 43,403 shares.","Securities sold in unregistered private placement under Rule 506(b) and Section 4(a)(2) of the Securities Act.","Shares are restricted and not registered under the Securities Act; transfer is subject to exemption requirements.","Funds used for general corporate purposes; no material change in control or business operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161187,"accession_number":"0001213900-25-043324","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-05-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai Q1 2025 revenue $5.4M down 27% YoY; operating loss narrows 45% to $2.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $5.4M, down $2.0M (27%) vs Q1 2024; operating expenses cut 33% to $7.7M.","Operating loss improved 45% to $2.3M; net loss $3.1M improved 29% vs prior year.","EPS of ($0.21), improvement of $0.25 per share year over year.","Unrestricted cash $0.7M at quarter end; CEO targets profitability and positive cash flow by end of 2025.","Key initiatives: launch of Healthcare Management tool with Empara, MarpaiRx advancements, new COO Dallas Scrip onboarded."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":5418000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161186,"accession_number":"0001213900-25-042317","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Marpai appoints Dallas Scrip as COO effective June 2, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dallas Scrip appointed COO and President of MarpaiRx, effective June 2, 2025.","Base salary $250,000; 2025 bonus up to $125k if Company profitable by year-end.","300,000 RSUs vesting over three years; additional 100k RSUs upon $5M EBITDA target.","2026 bonus tiers: up to $250k if net income $7M and revenue $100M.","Scrip previously President of ValueHealth Benefit Administrators and Centivo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179349,"accession_number":"0001013762-25-002843","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-03-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai Q4 net loss improves 67.5% YoY; full-year adjusted EBITDA loss narrows to $9.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $6.6M, down 6% sequentially; operating loss $2.7M, improved 12.2% from Q3.","Full-year 2024 net loss $22.1M, improved $6.7M (23.2%) vs 2023; EPS ($1.92), up $2.22.","Adjusted EBITDA loss for year $9.1M, vs $20.2M in 2023, citing cost actions.","CEO plans high-impact PBM-based products in H2 2025; targets profitability in 2025.","Webcast to discuss results on March 27, 2025 at 8:30 a.m. ET."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179348,"accession_number":"0001213900-25-010928","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Marpai reduces Base Purchase amounts by $3M with AXA; new payment schedule through 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Reduction criteria met as of Dec 31, 2024: largest shareholder contributed ≥$3M, listing maintained, timely payments.","Initial Base Amount reduced to $16.7M and Full Base Amount to $22.3M, each cut by $3M from prior amounts.","Modified annual aggregate payment minimums: 2024 $2.3M, 2025 $5.3M, 2026 $13.3M, 2027 $22.3M.","Debt Reduction Agreement executed Jan 31, 2025; all other Purchase Agreement terms unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179347,"accession_number":"0001213900-25-001170","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2025-01-06T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Marpai secures $5M additional non-dilutive debt financing from JGB","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Additional $5M financing from JGB Collateral LLC via senior secured debentures (principal $5.376M).","$2M received at closing; $3M held in escrow pending satisfaction of conditions.","New debentures have no conversion feature, making them non-dilutive to equity.","Proceeds to be used for growth initiatives and general working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196043,"accession_number":"0001213900-24-107406","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Marpai prices $702k private placement of 621,194 shares at $1.13 each","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Gross proceeds of $701,950 from sale of 621,194 Class A common shares at $1.13/share.","Investors include Chairman Yaron Eitan (110,619 shares), CFO Steve Johnson (5,000), and President John Powers (10,000).","Offering expected to close on or before December 6, 2024.","Net proceeds to be used for general working capital.","Securities sold in private placement exempt from registration under Rule 506(b)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196042,"accession_number":"0001213900-24-096102","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai reports Q3 2024 net loss of $3.6M, revenue down 20% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $7.0M, down 20% YoY from $8.7M in Q3 2023.","Operating loss improved 57% YoY to $3.1M from $7.1M.","Net loss improved 51% YoY to $3.6M; diluted EPS ($0.30) vs ($0.98).","Operating expenses fell 36% YoY to $10.1M from $15.8M.","CEO says turnaround progress continues; expects Q4 developments."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.96,"consensus_revenue_estimate":null,"consensus_revenue_actual":21582000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212291,"accession_number":"0001213900-24-075117","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-09-03T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai raises ~$1.3M via private placement of 2.7M shares at $0.481; CEO affiliate participates","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 2,702,702 shares at $0.481 per share, raising approximately $1.3 million.","HillCour Investment Fund, controlled by CEO Damien Lamendola, purchased 1,351,351 shares.","Offering exempt under Section 4(a)(2) and Rule 506(b) of Regulation D.","Shares are restricted and not registered under the Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212290,"accession_number":"0001213900-24-066183","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai Q2 net loss widens to $13M on $7.6M goodwill impairment; revenue drops 28%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $7.2M, down 28% YoY from $10.1M in Q2 2023.","Operating loss $12.3M vs. $7.3M YoY, with $7.6M goodwill and intangible impairment.","Net loss $13.0M ($1.23 per share) vs. $7.5M ($1.10) YoY.","CEO cites progress toward profitability; new sales pipeline for Q1 2025.","Company holds webcast on August 8, 2024 to discuss results."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":14574000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231227,"accession_number":"0001213900-24-055727","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-06-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Marpai redeems $5M of convertible debentures, reducing outstanding to $6.83M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Effective June 21, 2024, Marpai redeemed $5M principal of Senior Secured Convertible Debentures under optional provision.","Original issuance was $11.83M principal for $11M purchase price per April 2024 Securities Purchase Agreement.","After redemption, aggregate principal outstanding reduced to $6.83M.","Redemption limited to $5M within 60 days of issue, conditional on $5M held in blocked account."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231226,"accession_number":"0000950170-24-064564","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Marpai withdraws from Nasdaq hearings, expects delisting on May 29; trading to move to OTCQX","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marpai was not compliant with Nasdaq minimum stockholders' equity requirement under Rule 5550(b)(1).","Expects shares suspended effective May 29, 2024; trading to commence on OTCQX immediately under ticker MRAI.","Company states delisting reduces costs and management burden, allowing focus on driving profitable growth.","There is no guarantee a broker will continue to make a market or that trading will continue on OTCQX.","Company will remain subject to SEC periodic reporting requirements after delisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231225,"accession_number":"0000950170-24-059484","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Mike Dendy resigns from Marpai board effective May 12, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Mike Dendy resigned from the Board effective May 12, 2024.","Resignation not due to any disagreement with the Company on operations, policies, or practices.","No replacement director has been announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231224,"accession_number":"0000950170-24-056955","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai Q1 2024 net revenues $7.4M (-24% YoY); net loss improves 51% to $4.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $7.4M, down 24% YoY; gross profit $2.5M (-23% YoY).","Operating expenses $6.6M, down 44% YoY; operating loss $4.1M (-52% YoY).","Net loss $4.3M, improvement of 51% YoY; diluted EPS ($0.46) vs ($1.68) YoY.","Implemented additional cost-reduction program targeting $3M annual savings.","Added new 'off cycle' client in Q1 and expanded sales team with two industry executives."],"consensus_eps_estimate":-0.4386,"consensus_eps_actual":-0.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":7385000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231223,"accession_number":"0000950170-24-053591","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Marpai shareholders approve 2024 equity plan and blank-check preferred stock at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved 2024 Global Stock Incentive Plan with 4,604,962 for, 200,399 against.","Approved amendment to certificate of incorporation authorizing 2,000,000 shares of blank-check preferred stock (4,569,405 for).","Eight directors elected: Damien Lamendola, Yaron Eitan, Mike Dendy, Sagiv Shiv, Mohsen Moazami, Colleen DiClaudio, Jennifer Calabrese, Robert Pons; all with majority support.","Ratified UHY LLP as independent auditor for FY 2024 with 6,357,314 votes for.","Broker non-votes of 1,636,021 on all proposals except auditor ratification (no broker non-votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":231222,"accession_number":"0000950170-24-045089","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Marpai issues $11.83M convertible debentures; net proceeds $11M; conversion $3.00/share","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate principal $11.83M; purchase price $11M; OID of $830,000.","Interest at prime + 5.75%; monthly principal payments of $140k from Oct 2024; maturity Apr 2027.","Convertible at $3.00/share; anti-dilution floor at $2.23 (closing price on Apr 12, 2024).","Secured by first-priority liens on assets; guarantees from CEO Damien Lamendola and Hillcour Holding.","Registration required by May 30, 2024; liquidated damages for delay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249620,"accession_number":"0000950170-24-036583","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-03-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai Q4 2023 net revenues $8.7M up 14% YoY; net loss improved to $5.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenues $8.7M, up 14% YoY; gross profit $3.0M, up 6.5%.","Q4 operating loss $5.2M, improved 42.3% YoY; net loss $5.0M, improved 41.1%.","Q4 EPS ($0.65), improvement of $1.00 per share YoY.","Full year net revenues $37.2M, up 52.6% YoY; net loss $28.8M, up 8.6%.","CEO cites benefit of Maestro acquisition and corrective actions driving financial improvement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249619,"accession_number":"0000950170-24-030502","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-03-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Nasdaq panel grants Marpai extension to May 28 to meet $35M MVLS listing requirement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq Hearings Panel granted extension until May 28, 2024 to regain compliance with MVLS minimum of $35M.","Company must meet certain requirements by March 31, 2024 as condition of extension.","Marpai previously notified of deficiency in May 2023; hearing held Feb 22, 2024.","CEO states company has made progress on raising equity and improving efficiencies.","No assurance company will meet deadlines or ultimately regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249618,"accession_number":"0000950170-24-028393","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-03-08T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Marpai issues 910k shares at $1.65 to CEO-affiliated fund in private placement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 910,000 Class A common shares to HillCour Investment Fund LLC (CEO Damien Lamendola controls) at $1.65/share.","Gross proceeds of approximately $1.5 million; securities unregistered, exempt under Section 4(a)(2) and Rule 506(b).","Transaction closed March 7, 2024; price equal to consolidated closing bid price on Nasdaq that day.","Shares are restricted and not registered under the Securities Act; no general solicitation used."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249617,"accession_number":"0000950170-24-026853","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["8.01","2.02","9.01"],"status":"ready","headline":"Marpai reports preliminary Q4 2023 revenue $8.7M (+14% YoY), operating loss improves $5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 net revenues ~$8.7M, up ~14% from Q4 2022; FY 2023 net revenues ~$37.2M, up ~53% YoY.","Q4 2023 operating expenses ~$6.9M, down ~41% YoY; FY operating expense ratio improved to 107% of rev from 140%.","Q4 2023 operating loss ~$3.9M, an improvement of ~$5.0M vs Q4 2022; FY operating loss ~$26.7M, down slightly YoY.","Company expects a $3.0M non-cash goodwill impairment charge in Q4 2023.","Full audited results to be reported on March 26, 2024, with a webcast on March 27."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249612,"accession_number":"0000950170-24-027115","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K/A","filed_at":"2024-03-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Marpai reports preliminary Q4 revenue up 14% YoY, operating loss improves $5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 net revenue ~$8.7M (+14% YoY); FY2023 ~$37.2M (+53% YoY).","Q4 operating expenses down 41% to ~$6.9M; FY operating expenses 107% of revenue vs 140% prior year.","Q4 operating loss ~$3.9M, a $5.0M improvement from Q4 2022; FY loss ~$26.7M slightly down.","Expects $3.0M non-cash goodwill impairment charge in Q4 2023.","Preliminary results subject to completion of audit; full earnings due March 26, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249616,"accession_number":"0000950170-24-025885","cik":1844392,"company_name":"Marpai, Inc.","ticker":"MRAI","form_type":"8-K","filed_at":"2024-03-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Marpai signs three-year off-cycle TPA agreement for at least 20,000 households","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Three-year healthcare benefit services contract with a regional southeast organization.","Agreement commenced March 2024; expected to bring at least 20,000 households by end of 2024.","Marpai cites custom solution, quick deployment, and cost savings as key win factors.","New client is off the normal calendar-year benefit cycle, highlighting market demand."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":20182537.88131343,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}